Cargando…

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used psychopharmaceutical treatment for major depressive disorder (MDD), but individual responses to SSRIs vary greatly. CYP2C19 is a key enzyme involved in the metabolism of several drugs, including SSRIs. Variations in the CYP2C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Win Lee Edwin, Fabbri, Chiara, Laplace, Benjamin, Li, Danyang, van Westrhenen, Roos, Lewis, Cathryn M., Dawe, Gavin Stewart, Young, Allan H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535191/ https://www.ncbi.nlm.nih.gov/pubmed/37765085 http://dx.doi.org/10.3390/ph16091277

Ejemplares similares

Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017)

Pre-clinical evaluation of CYP 2D6 dependent drug–drug interactions between primaquine and SSRI/SNRI antidepressants
por: Jin, Xiannu, et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Identification of SSRI-evoked antidepressant sensory signals by decoding vagus nerve activity
por: West, Christine L., et al.
Publicado: (2021)

Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies
por: Li, Danyang, et al.
Publicado: (2023)

Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments
por: Gupta, Ramesh K, et al.
Publicado: (2006)

Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants
por: Herzallah, Mohammad M., et al.
Publicado: (2013)

Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
por: Ben-Sheetrit, Joseph, et al.
Publicado: (2023)

Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022)

Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain
por: Orrico-Sanchez, Alejandro, et al.
Publicado: (2023)

Investigating the role of the relaxin-3/RXFP3 system in neuropsychiatric disorders and metabolic phenotypes: A candidate gene approach
por: Wong, Win Lee Edwin, et al.
Publicado: (2023)

The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)

Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank
por: Fabbri, Chiara, et al.
Publicado: (2023)

Exploring Health in the UK Biobank: Sociodemographic, Psychosocial, Lifestyle and Environmental Factors
por: Mutz, Julian, et al.
Publicado: (2021)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2016)

Evaluation of the effect of long-term use of antidepressants in the SSRI group on bone density with dental volumetric tomography
por: Agacayak, Kamil Serkan, et al.
Publicado: (2019)

Mapping the physiological and molecular markers of stress and SSRI antidepressant treatment in S100a10 corticostriatal neurons
por: Sargin, Derya, et al.
Publicado: (2019)

TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli
por: Ou, Jin, et al.
Publicado: (2022)

Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment
por: Liao, Huijuan, et al.
Publicado: (2023)

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

ukbtools: An R package to manage and query UK Biobank data
por: Hanscombe, Ken B., et al.
Publicado: (2019)

Genetic stratification of depression in UK Biobank
por: Howard, David M., et al.
Publicado: (2020)

Examining the association between family status and depression in the UK Biobank
por: Giannelis, Alexandros, et al.
Publicado: (2021)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
por: Sikka, Pranav, et al.
Publicado: (2011)

Meaning and medication: a thematic analysis of depressed adolescents’ views and experiences of SSRI antidepressants alongside psychological therapies
por: Maroun, Rita A., et al.
Publicado: (2018)

Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression
por: Malki, Karim, et al.
Publicado: (2016)

Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder
por: Khandker, Rezaul K., et al.
Publicado: (2008)

SSRI Facilitated Crack Dancing
por: Doobay, Ravi, et al.
Publicado: (2017)

Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
por: Hardoy, Maria Carolina, et al.
Publicado: (2010)

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
por: Zoega, Helga, et al.
Publicado: (2015)

Do Triptan Antimigraine Medications Interact with SSRI/SNRI Antidepressants? What Does Your Decision Support System Say?
por: Kogut, Stephen J.
Publicado: (2011)

Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK Biobank
por: Glanville, Kylie P., et al.
Publicado: (2021)

The UK Biobank resource with deep phenotyping and genomic data
por: Bycroft, Clare, et al.
Publicado: (2018)

Exploring health in the UK Biobank: associations with sociodemographic characteristics, psychosocial factors, lifestyle and environmental exposures
por: Mutz, Julian, et al.
Publicado: (2021)

5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients
por: Dong, Zai-Quan, et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark
por: Jordan, Sue, et al.
Publicado: (2016)

An atlas of mitochondrial DNA genotype-phenotype associations in the UK Biobank
por: Yonova-Doing, Ekaterina, et al.
Publicado: (2021)

Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
por: Jha, Manish K, et al.
Publicado: (2017)

Effects of SSRI Antidepressants on Attentional Bias toward Emotional Scenes in First-Episode Depressive Patients: Evidence from an Eye-Tracking Study
por: Zhang, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_poocd8rr19ak0504s67mo51pn7